Gregory (Gregg) S. Day, M.D Twitter Google I maintain special clinical interest in the diagnosis and management of patients with rapidly progressive dementia (including Creutzfeldt-Jakob disease), and autoimmune-mediated encephalitis (including patients with NMDA-receptor encephalitis and similar diseases). My research strives to integrate clinical (e.g., symptoms and signs) and paraclinical measures (e.g., structural/functional/PET neuroimaging, cerebrospinal fluid biomarkers) […]
Rachel Buckley, PhD Linkedin Twitter Google Rachel is a lead investigator of the Healthy Brain Project and an early career research fellow at Harvard Medical School and The Florey Institute of Neuroscience and Mental Health. Her research interests focus on early detection of dementia via subjective concerns of memory decline and determining the reliability of
Anthony Filiano, PhD Linkedin Twitter Google Immune dysfunction has been described in most neurological disorders. Preclinical strategies targeting these disorders have primarily concentrated on directly targeting synaptic function; however, most of these approaches have failed. Our lab is interested in understanding the complex interactions between the immune system and nervous system with the intent to
Veronique Belzil, PhD Linkedin Google Dr. Belzil is an Associate Professor of Neurology at Vanderbilt University Medical Center where she also serves as the Director of the Vanderbilt ALS Research Center. She obtained her bachelor’s degree in psychology from McGill University in 2003 and her master’s degree in psychology from Walden University in 2007. Continuing
